Emerging Cytomegalovirus Management Strategies After Solid Organ Transplantation: Challenges and Opportunities
- 2 July 2014
- journal article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 16 (9) , 1-10
Abstract
Cytomegalovirus (CMV) remains as one of the most common pathogens after solid organ transplantation (SOT). During the past year, management guidelines were updated, and numerous studies were published—all collectively emphasizing the ongoing efforts to improve management of CMV after SOT. Improvement in laboratory diagnostics was aided by the WHO international calibration standard for nucleic acid testing, which allows for meaningful comparison of viral load values among laboratories. The potential translation of methods for assessing CMV-specific cellular immunity could provide tools for CMV risk assessment and management. Efforts continue to optimize antiviral strategies for CMV disease prevention and treatment. CMV vaccines continue to be tested in various stages of clinical trials. Novel anti-CMV drugs are being developed, including agents that have been used as compassionate therapy for treatment of drug-resistant CMV. In this article, the authors review recent developments on CMV and discuss their implications in CMV management after transplantation.Keywords
This publication has 61 references indexed in Scilit:
- Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2013
- Cytomegalovirus polyradiculopathy of late onset in a young renal transplant recipientClinical Nephrology, 2013
- CMV Infection in the Donor and Increased Kidney Graft Loss: Impact of Full HLA-I Mismatch and Posttransplantation CD8+ Cell ReductionAmerican Journal of Transplantation, 2013
- Cytomegalovirus in Solid Organ TransplantationAmerican Journal of Transplantation, 2013
- Pretransplant Interferon-γ Secretion by CMV-Specific CD8+ T Cells Informs the Risk of CMV Replication After TransplantationAmerican Journal of Transplantation, 2013
- Prospective study on CMV-reactivations under preemptive strategy in CMV-seropositive adult liver transplant recipientsJournal of Clinical Virology, 2013
- Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experienceNephrology Dialysis Transplantation, 2012
- An International Multicenter Performance Analysis of Cytomegalovirus Load TestsClinical Infectious Diseases, 2012
- Antiviral Drug Resistance of Human CytomegalovirusClinical Microbiology Reviews, 2010
- Vaccine Prevention of Maternal Cytomegalovirus InfectionNew England Journal of Medicine, 2009